ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers.
Episodes
Thursday Jul 20, 2023
Thursday Jul 20, 2023
This podcast, produced by ASHP’s Pharmacy Administration and Leadership Residents’ Collaborative (PALRC), delivers an engaging interview with two distinguished pharmacy leaders who have embraced lifelong learning to serve the profession. Jordan Dow and Majid Tanas share their approaches and discuss the importance of lifelong learning.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday Jul 19, 2023
Wednesday Jul 19, 2023
With the release of the revised USP <797> guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and changes from low, medium, and high risk compounding categories. In this third episode of the series, speakers will focus on one of the most significant changes between the currently enforceable version and the upcoming version: the change from low, medium, and high risk to category 1, 2, and 3 compounding and how this impacts BUDs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tuesday Jul 18, 2023
Tuesday Jul 18, 2023
International interest in US-based pharmacy residency training has grown in recent years. With a reduced US pharmacy student pipeline, the desire for health-systems to hire international candidates into residencies is likely to increase. Many Pharmacy administrators and Resident Program Directors in the US are not familiar with visa restrictions for international trainees. This podcast will shed light on training visas and perspectives on this topic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Monday Jul 17, 2023
Monday Jul 17, 2023
Join this three-part conversation with Dr. Blake Porter, Dr. Shareen El-Ibiary, and Dr. Justin Konkol – experienced pharmacy educators, well-being leaders, and recent participants in ASHP’s Well-Being Ambassador Program. Each episode will discuss their journeys exploring and implementing WBR principles, while leading the way for their learners and organizations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Sunday Jul 16, 2023
Sunday Jul 16, 2023
In this Management Case Study from the 2022 Midyear Clinical Meeting, our content matter experts identify considerations for implementation of IV chemotherapy robotic technology into a cancer center’s care model, discuss methods to optimize IV chemotherapy robotic technology workflow integration and review benefits of using IV chemotherapy compounding robotic technology.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Saturday Jul 15, 2023
Saturday Jul 15, 2023
With the release of the revised USP <797> guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and changes from low, medium, and high risk compounding categories. In this second episode of the series, speakers will discuss details around beyond use dating assignments and how that applies to various types of products in our compounding practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Friday Jul 14, 2023
Friday Jul 14, 2023
In this episode, our content matter experts present recent changes to sterile and non-sterile compounding guidance in the USP chapters at the 2022 Midyear Clinical Meeting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Monday Jul 10, 2023
Monday Jul 10, 2023
Describe the keys to success for succession planning with the pharmacy enterprise to solidify a strong leadership team. Share internal and external tools available to engage emerging leaders to promote professional growth. Share success stories of individuals that have received the benefit of deliberate succession planning.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Monday Jul 10, 2023
Monday Jul 10, 2023
This podcast will focus on Pharmacoequity; what it is and ways to address it.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Sunday Jul 09, 2023
Sunday Jul 09, 2023
In this episode from the 2022 Midyear Clinical Meeting, content matter experts discuss the ongoing database development focused on predicting drug event risks in pediatric patient.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.